Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate McKesson Corporation before investing.
In this article, we go over a few key elements for understanding McKesson Corporation’s stock price such as:
- McKesson Corporation’s current stock price and volume
- Why McKesson Corporation’s stock price changed recently
- Upgrades and downgrades for MCK from analysts
- MCK’s stock price momentum as measured by its relative strength
About McKesson Corporation (MCK)
Before we jump into McKesson Corporation’s stock price, history, target price and what caused it to recently rise, let’s take a look at some background.
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: North American Pharmaceutical, Oncology & Multispecialty, Prescription Technology Solutions, and Medical-Surgical Solutions. The company distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products; delivers products to retail pharmacies, hospitals, long-term care centers, clinics, and institutions; and provides logistics and distribution services for manufacturers. It also provides consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies; gene therapy with InspiroGene, practice consulting, and vaccine distribution services; and technology solutions, as well as research, insights, technologies, and services to improve cancer and specialty care. In addition, the company helps in solving medication access, affordability, and adherence challenges for patients by working across healthcare to connect patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies. Further, it offers technology services, which includes electronic prior authorization, prescription price transparency, benefit insight, dispensing support services, patient enrollment, third-party logistics, and wholesale distribution support; medical-surgical supplies, laboratory equipment, pharmaceutical distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, and hospital reference labs, nursing homes, hospice and home health care agencies, government facilities ,and online marketplaces and retailers. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.
Want to learn more about McKesson Corporation’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about McKesson Corporation.
McKesson Corporation’s Stock Price as of Market Close
As of October 08, 2026, 4:00 PM, CST, McKesson Corporation’s stock price was $930.250.
McKesson Corporation is up 2.19% from its previous closing price of $910.330.
During the last market session, McKesson Corporation’s stock traded between $906.650 and $938.510. Currently, there are approximately 118.70 million shares outstanding for McKesson Corporation.
McKesson Corporation’s price-earnings (P/E) ratio is currently at 24.3, which is low compared to the Health Care Providers & Services industry median of 25. The price-earnings ratio gauges market expectation of future performance by relating a stock’s current share price to its earnings per share.
McKesson Corporation Stock Price History
McKesson Corporation’s (MCK) price is currently up 8.95% so far this month.
During the month of October, McKesson Corporation’s stock price has reached a high of $938.510 and a low of $881.340.
Over the last year, McKesson Corporation has hit prices as high as $999.000 and as low as $723.680. Year to date, McKesson Corporation’s stock is up 13.41%.
Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions
What Caused McKesson Corporation Stock’s Price to Rise?
Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?
When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of October 07, 2026, there was 1 analyst who downgraded McKesson Corporation’s stock and 1 analyst who upgraded over the last month.
Additionally, you'll want to evaluate McKesson Corporation’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on McKesson Corporation’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.
McKesson Corporation’s current valuation based on AAII’s Value Grade is a B, which means it is considered to be Value.
Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.
Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about McKesson Corporation (MCK) by visiting AAII Stock Evaluator.
Relative Price Strength of McKesson Corporation
Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.
For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.
As of October 07, 2026, McKesson Corporation has a weighted four-quarter relative price strength of 3.33%, which translates to a Momentum Score of 72 and is considered to be Strong.
Want to learn more about how McKesson Corporation is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.
McKesson Corporation Stock Price: Bottom Line
As of October 8, 2026, McKesson Corporation’s stock price is $930.250, which is up 2.19% from its previous closing price.
AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like McKesson Corporation stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.
Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.
Included With AAII Platinum
at only 6.9%
Gain Since Inception. Data as of 12/31/2024.
769.3% Stock Superstars Portfolio Total Return Since Inception
U.S. Index ETF (IYY)
SSR Group 3 O'Shaughnessy portfolio has a 411.2% gain since inception performance compared to IYY at only 119.1%% Performance as of 11/29/24.
FREE REPORT
BECOME A MEMBER FOR ONLY $2
Get access to powerful investment discovery tools and a wealth of investment education to help you achieve your financial goals.